An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
Please join us in welcoming Michal Nisnboym Ziv, MD, to UPMC Hillman Cancer Center, effective August 25, 2025. Dr. Nisnboym Ziv is Assistant Professor in the Department of Neurology at the University of Pittsburgh and is affiliated with UPMC Magee-Womens…
Please join us in congratulating Dayana Rivadeneira, PhD, in her new role as Assistant Professor in the Department of Immunology at the University of Pittsburgh and UPMC Hillman Cancer Center, effective September 1, 2025. She will develop an independently funded…
We are pleased to announce that Greg M. Delgoffe, PhD, has agreed to serve as Associate Director (AD) for Basic Science at UPMC Hillman Cancer Center, effective September 1, 2025. Dr. Delgoffe is a distinguished and integral part of the…
We are pleased to announce that Carola Neumann, MD, has agreed to serve as the Program Co-Director of the Oncology Graduate Program, effective September 1, 2025. Dr. Neumann is an associate professor of Pharmacology and Chemical Biology and serves as…
We are pleased to announce James Ohr, DO, as Director of the Northwest Pennsylvania Clinical Trials Program for UPMC Hillman Cancer Center, effective August 1, 2025. In this new role, Dr. Ohr will provide leadership for our OHA medical oncology…
Breast cancer is the most commonly diagnosed cancer among women worldwide. Patients diagnosed with breast cancer face the important question of what treatments to choose. While treatment decisions have become more refined over time, they are not yet personalized. Patients…
We are pleased to announce Yana Najjar, MD, as the recipient of this year’s Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy. Dr. Najjar is a research physician at UPMC Hillman Cancer Center, where is…
Please join us in welcoming Shirley S. Ong, MD, to UPMC Hillman Cancer Center, effective March 17, 2025. Dr. Ong is Associate Professor in the Department of Neurology. Dr. Ong will be involved in clinical research, developing and running clinical…
In honor of April being Head and Neck Cancer Awareness Month, we wanted to catch up with Marci Nilsen, PhD, RN, CHPN, FAAN, who we featured a couple years ago and was recently named co-lead for our cancer center’s Biobehavioral…
We are pleased to announce Hong Wang, PhD, as interim director of the Biostatistics Facility and Raman Venkataramanan, PhD, FCP, FAAPS, as interim director of the Cancer Pharmacokinetics and Pharmacodynamics Facility. Dr. Wang has been a biostatistician in the Biostatistics…
